key: cord-0975852-ohyhox9p
authors: Jahn, Kathleen; Sava, Mihaela; Sommer, Gregor; Schumann, Desiree M.; Bassetti, Stefano; Siegemund, Martin; Battegay, Manuel; Stolz, Daiana; Tamm, Michael; Khanna, Nina; Hostettler, Katrin E.
title: Exercise capacity-impairment after COVID-19 pneumonia is mainly caused by deconditioning
date: 2021-11-04
journal: Eur Respir J
DOI: 10.1183/13993003.01136-2021
sha: 6899ee83fb9faef60838a1b3bda7e90a8447cf2b
doc_id: 975852
cord_uid: ohyhox9p

The new severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) can cause severe pneumonia characterised by dry cough, dyspnea, hypoxaemia, and diffuse ground glass opacities on chest computed tomography (CT) [1]. While much has been learnt concerning diagnosis and treatment of COVID-19 during the first year of the pandemic, only scarce data is available concerning post-COVID long-term pulmonary sequelae. Data about pulmonary function in the early convalescence demonstrated impaired diffusion capacity, lower respiratory muscle strength, and radiological abnormalities [2, 3]. Herein we report data of cardio-pulmonary exercise testing (CPET) three months after severe COVID-19 pneumonitis.

The new severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) can cause severe pneumonia characterized by dry cough, dyspnea, hypoxaemia, and diffuse ground glass opacities on chest computed tomography (CT) [1] . While much has been learnt concerning diagnosis and treatment of COVID-19 during the first year of the pandemic, only scarce data is available concerning post-COVID long-term pulmonary sequelae. Data about pulmonary function in the early convalescence demonstrated impaired diffusion capacity, lower respiratory muscle strength, and radiological abnormalities [2, 3] . Herein we report data of cardio-pulmonary exercise testing (CPET) three months after severe COVID-19 pneumonitis.

Between February 26 and May 3, 2020, 221 patients with RT-PCR-confirmed SARS-CoV-2 infection were admitted to the University Hospital Basel, Switzerland. A total of 50 (22.6%) patients suffered from severe COVID-19 pneumonitis, fulfilling ≥ 2 of the following criteria: respiratory rate > 30/min, SpO2 < 93% while breathing ambient air, C-reactive protein (CRP) levels > 75 mg/l (normal < 10.0 mg/l), ground glass opacities or diffuse infiltrates on CT-scan or progression of > 50% within 24-48 hours or typical findings  4 lobes [4] . Patients were treated according to local standard at that time, and only one patient received systemic corticosteroids (cumulative dose of 80 mg prednisone); all patients were included in an observational study (NCT04351503).

During hospitalization 5/50 (10%) patients died due to COVID-19. One further patient succumbed to pre-existing haematological disease after hospital discharge. Among the 44 COVID-19 survivors, four experienced prolonged hospitalization with oxygen dependency. Further five patients declined the performance of CPET. All patients received physiotherapy during their hospitalization; after discharge, 8/35 (23%) patients were transferred to further inpatient pulmonary rehabilitation, 3/35 (9%) patients underwent outpatient pulmonary rehabilitation. In all these patients, pulmonary rehabilitation programs were completed at the time of CPET.

In the context of this analysis, patients were followed-up including clinical status, bodyplethysmography and chest CT-scan three months after COVID-19 pneumonitis.

All 35 patients underwent an incremental CPET using a cycle ergometer [5] (Ergoline Ergoselect 1000) in semi-recumbent position in continuous ramp mode (10-20W/min).

CPET parameters were systematically computed according to breath-by-breath analysis and data were displayed online (Sentry Suite Version 3.10). Arterial blood gas analysis at rest and at maximal exercise level was performed (ABL 800 Flex). The level of dyspnea and exhaustion at peak exercise was objectified using the Borg modified scale [6] . The evaluation of the collected data was in accordance with Wassermann algorithm [7] and the adaptation of Schmid et al. [8] . Health-related quality of life (QoL) was evaluated using the St. George Respiratory Questionnaire (SGRQ) and the King's Brief Interstitial Lung Disease (K-BILD) questionnaire. Chest CT scans were conducted on a dual source CT scanner (Somatom Definition Flash, Siemens Healthineers) using dual-energy acquisition after intravenous injection of iodine contrast material in the late pulmonary arterial phase. Mann-Whitney-U test was computed to assess statistical differences; a p-value <0.05 was considered statistically significant. Contrary to our expectations, both in patients with and without lung function impairment, the most common main limiting factor of VO2max was not of pulmonary nature, but general deconditioning. Of note, maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) were normal in those patients with deconditioning (mean MIP 99.4% predicted, mean MEP 79.9% predicted), making it unlikely that neuro-muscular impairment caused the limitation. Three of the nine patients with deconditioning were obese. In 14% of the patients (5/35) cardiovascular limitation of CPET was observed. From those, three had previous CVD. Only one of the five patients with pulmonary limitation had a preexisting respiratory disease, i.e. severe obstructive sleep apnea. Health related QoL was not better in those with normal VO2max as compared to those with impaired maximal oxygen uptake. However, this finding is limited by the fact that 40% of patients did not complete the questionnaires, though equally distributed in both groups (42% vs 37.5%).

Our data on PFT impairment after COVID-19 pneumonitis are in line with previous publications [2, [9] [10] [11] . The low prevalence of respiratory comorbidities and active smoking in our population might partially explain the finding of 66% normal PFT three months after severe COVID-19. Impairment of physical performance in patients recovering from COVID-19 pneumonia has been described before [2, 3, 10, 12] . To date, there are accumulating data on CPET after SARS-CoV-2 infection [13] [14] [15] [16] [17] [18] , but only limited respective information on patients surviving severe COVID-19

pneumonitis. In our well-characterized patient group, almost half (46%) had normal VO2max in CPET. In those patients with impaired maximal oxygen uptake, the majority (47%) was limited by deconditioning. Thus, despite the severity of the acute COVID-19 pneumonitis, only 14% of survivors exhibited pulmonary limitation in CPET three months later, demonstrating a surprisingly good pulmonary recovery. This applies even more in the light of the predominant lung pathology observed in patients with severe COVID-19, i.e. diffuse alveolar damage, endothelitis, and pulmonary immunothrombosis [19] .

In a previous issue of this journal, Skjorten et al. reported a reduced VO2max in onethird of COVID-19 patients three months after hospital discharge, with deconditioning being the major cause of exercise limitation [15] . Compared to these findings, we observed a higher proportion of patients with impaired peak oxygen uptake (54%), which is likely due to the more severe disease course in our patient group, as depicted by the longer length of hospital stay (median 14 day versus median 6 days) [15] . The study by Rinaldo et al. reported CPET-data in a mixed group of patients with critical, severe, and mild-moderate COVID-19 [13] . Even though we included only patients with severe COVID-19 pneumonia, the mean VO2max %pred of 82% in our study population is surprisingly similar to the one reported by Rinaldo et al. (83%) . A striking disparity between the two patient groups is the portion of active smokers, being only 2.9% in our population as compared to 19% in the group studied by Rinaldo. This might at least partiallyexplain the good outcome in our patients. Finally, in line with our data, Rinaldo et al. found muscle deconditioning to be the main cause of reduced exercise capacity [13] . In a very small group of 10 moderate and severe COVID-19 patients, Gao et al. performed CPET one month post-discharge [20] . In contrast to our data, Gao et al. found reduced peak oxygen uptake in all cases, an apparent contradiction which might be explained by the two months later follow-up time-point of our study. However, similar to us, Gao et al. showed that extrapulmonary factors were the main reason for exercise limitation [20] . Notably, our findings are in line with CPETdata from survivors of the 2002 coronavirus-induced SARS outbreak: three months after SARS, 41% of the patients showed reduced VO2max; none of these patients had pulmonary limitation, but extrapulmonary diseasemainly impaired muscle functioncaused reduced VO2max [21] . Furthermore, similar data were found in survivors of severe ARDS caused by various etiologies [22] . By performing CPET three months after severe COVID-19, a time point by which most radiological abnormalities related to the acute infection had vanished, we were able to demonstrate that half of the patients have reduced exercise capacity, yet, only a minority of patients have pulmonary limitation. Thus, CPET is a helpful tool to further dissect reduced exercise tolerance and interpret exertional dyspnea. With similar previous findings in survivors of SARS, physical deconditioning seems to be the main cause of impaired exercise capacity after severe coronavirus infections, and might even represent the natural course after severe lung injury with critical illness in general.

In summary, we demonstrate that physical deconditioning is the most common cause of impaired VO2max in patients after severe COVID-19 pneumonitis. Whether these findings are specific to SARS-CoV2 infection or contrariwise depict the common sequelae after ARDS caused by any insult has to be further explored. Finally, our findings underscore the importance of an early rehabilitative intervention in survivors of severe COVID-19 pneumonitis. 

CT imaging changes of corona virus disease 2019(COVID-19): a multicenter study in Southwest China

Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase

Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab -a single centre cohort study

Recommendations on the use of exercise testing in clinical practice

Psychophysical scaling with applications in physical work and the perception of exertion. Scand J Work Environ Health

Principles of Exercise Testing and Interpretation

Design and validation of an interpretative strategy for cardiopulmonary exercise tests

Cardiopulmonary recovery after COVID-19 -an observational prospective multi-center trial

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

Muscle Strength and Physical Performance in Patients Without Previous Disabilities Recovering From COVID-19 Pneumonia

Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors

Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing

Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up

Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients

Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome

Long-term assessment of lung function in survivors of severe ARDS